That’s correct. In a 200+ patient Phase 2B a SINGLE dose of Brilacidin was non-inferior (eg as good) to billion dollar blockbuster Dapto in a 7 day treatment. The anti-infective market has been horrible over the last five years—until now. New interest with something called a pandemic.
This drug is safe and powerful. People need to understand it has been tested in over 400 living humans. That’s why they can jump right into. Phase 2 trial. And will be able to skip a Phase 3 if the Phase 2 results are strong...